Biotech VC chief Alex Barkas dies; Malaysia creates $100M biotech fund; GW Pharma outlines PhIII schedule for Sativex;

 @FierceBiotech: Biotech building boom restricted to top "micro" hot spots. News | Follow @FierceBiotech

 @JohnCFierce: Radius Health has closed a $27M tranche of its $91M financing round. | Follow @JohnCFierce

 @RyanMFierce: Otsuka filed NDA for once-monthly version of Abilify, Alkermes ($ALKS) has rival drug in its pipeline. Report | Follow@RyanMFierce

 @MaureenFierce: 2011 Fierce 15 winner Selecta Biosciences starts Phase I trial of synthetic nano-vaccine for smoking. Item | Follow@MaureenFierce

> Alex Barkas, the managing director at Prospect Venture Partners, has died. He was 64. Story

> The Malaysian Biotechnology Corporation has put together a $100 million venture fund for the country. Report

> The UK's GW Pharma plans to wrap late-stage testing of its cannabis-based Sativex for cancer pain by late 2013. An approval could help push European sales of the drug, approved for MS, to more than $250 million, according to analysts. Story

> India's Transgene Biotek has moved its recombinant human erythropoietin technology to Germany's TSS Export for $5 million. Story

> Proximagen and Altacor have struck a collaboration deal on a glaucoma program. Story

> Belgium's Galapagos NV says its JAK1 inhibitor, GLPG0634, achieved the primary endpoint of significant improvement in the signs and symptoms of rheumatoid arthritis in a Phase II study. Release

Pharma News

 @FiercePharma: Merck criminal plea on Vioxx misbranding: DoJ says $MRK promoted for RA three yrs before FDA approved for that use.Release | Follow @FiercePharma

> EMA pulls cancer meds made by troubled CMO. Report

Vaccine News

> Study: Vaccine developers should target deadliest cancers. Article

> Selecta starts trial of synthetic nano-vaccine for smoking. News

> Combo vaccines may cost doctors money. Report

Drug Delivery News

> Will third time be the charm for Transcept's sleep drug? Article

> Drug coupled with peptide delivers targeted tumor treatment. Story

> FDA accepts Otsuka's app for long-lasting Abilify. Report

> Drug coupled with peptide delivers targeted tumor treatment. News

> Drug delivery may be possible through new polymer bathed in infrared light. Report

Medical Device News

> Flexuspine adds $2.1M to Series B. News

> Boston Scientific gets FDA nod for heart stent. More

> Sphere gets regulatory OK for manufacturing products in U.K. facility. Item

And Finally...Investigators at the NYU School of Medicine say they've found a potential Achilles' Heel for bacteria, opening up a promising pathway for developers of antibiotics. Release